Flushing Hospital Medical Center is one of the oldest hospitals in New York City. It survived a 1999 bankruptcy and subsequently affiliated first with the New York Presbyterian Hospital and then with the MediSys Health Network.

During the past decade, Flushing Hospital Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Flushing Hospital Medical Center" #1 sponsor was "Daniel Benjamin" with 1 trials, followed by "Genentech, Inc." with 1 trials sponsored, "MediSys Health Network" with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "New York State Psychiatric Institute" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Flushing Hospital Medical Center" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Flushing Hospital Medical Center" are "Adherence, Patient" (1 trials), "Bariatric Surgery Candidate" (1 trials), "COVID-19 Pneumonia" (1 trials), "Communication" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Flushing Hospital Medical Center" in a lesser frequency.

Most popular intervention types in "Flushing Hospital Medical Center" are "Drug" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abatacept" (1 trials), "Infliximab" (1 trials), "Omr-lgG-am" (1 trials) and "Osteopathic Manipulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Flushing Hospital Medical Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Flushing Hospital Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Flushing Hospital Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Flushing Hospital Medical Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".